HRT and breast cancer risk

Affiliations

¹ Royal College of Obstetricians and Gynaecologists, London, UK janice.rymer@kcl.ac.uk.
² Royal College of Obstetricians and Gynaecologists, London, UK.

Editorial

Janice Rymer et al. BMJ. 2019.

. 2019 Oct 11:367:l5928.

doi: 10.1136/bmj.l5928.

¹ Royal College of Obstetricians and Gynaecologists, London, UK janice.rymer@kcl.ac.uk.
² Royal College of Obstetricians and Gynaecologists, London, UK.

No abstract available

Conflict of interest statement

Competing interests: We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare.

Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
Collaborative Group on Hormonal Factors in Breast Cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet. 2019 Sep 28;394(10204):1159-1168. doi: 10.1016/S0140-6736(19)31709-X. Epub 2019 Aug 29. Lancet. 2019. PMID: 31474332 Free PMC article.